申请人:VERTEX PHARMACEUTICALS INCORPORATED
公开号:US20130090351A1
公开(公告)日:2013-04-11
Compounds represented by formula I
or pharmaceutically acceptable salts thereof, wherein A, B, B′, X, Y, R
1
, R
2
, R
2
′, R
3
, R
3
′, R
4
, R
4
′, R
5
, R
5
′, m, n, or p are as defined herein, are useful for treating flaviviridae viral infections.
公式I所代表的化合物或其药学上可接受的盐,其中A、B、B'、X、Y、R1、R2、R2'、R3、R3'、R4、R4'、R5、R5'、m、n或p的定义如本文所述,对于治疗黄病毒科病毒感染是有用的。